Factor VII Inhibitor Profile, Professional Interpretation
Use
Coagulation factor inhibitors, such as those related to factor VII, can arise in patients with congenital deficiency or spontaneously. These inhibitors may develop in response to factor replacement therapy or occur due to various medical conditions, including postpartum state, immunologic disorders, antibiotic therapies, or malignancies. This profile assists in interpreting testing for the detection and quantitation of inhibitors to factor VII, aiding in diagnosis and management of related conditions.
Special Instructions
This test is not orderable as a primary option but only as a reflex. For further analysis, refer to the main test 7INHE / Factor VII Inhibitor Evaluation, Plasma. The test must be administered within Mayo Clinic Laboratories' guidelines, and it's performed Monday through Friday, requiring frozen plasma samples for accurate evaluation.
Limitations
The test is specifically designed to detect and quantify inhibitors to factor VII and may not provide comprehensive data on other coagulation factors. Additionally, proper specimen handling and adherence to testing protocols are crucial to avoid diagnostic errors. Conditions affecting the provision of accurate plasma samples, such as improper collection, may impact test reliability.
New York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 69049-5
- 18771-6
- 69049-5
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
Not provided
Minimum Volume
Not provided
Container
Plasma Na Cit
Storage Instructions
Frozen for 14 days
Stability Requirements
| Temperature | Period |
|---|---|
| Frozen | 14 days |